Browse Health
Pathologist, Hematology Specialist
12 years of experience


Education ?

Medical School Score
Ohio University (2000)

Awards & Distinctions ?

American Board of Pathology

Affiliations ?

Dr. Fuda is affiliated with 1 hospitals.

Hospital Affiliations



  • Children's Medical Center of Dallas
    1935 Motor St, Dallas, TX 75235
    Top 25%
  • Publications & Research

    Dr. Fuda has contributed to 4 publications.
    Title Notch1 in Primary Effusion Lymphoma: a Clinicopathological Study.
    Date September 2010
    Journal Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc

    Primary effusion lymphoma is a human herpes virus 8 (HHV-8)-associated large cell lymphoma of body cavities. Detailed large-scale clinicopathological studies are rarely reported, and the underlying mechanism of lymphomagenesis remains elusive. In the present report, we studied the clinicodemographic, immunophenotypic, and cytomorphological features on a cohort of 12 cases of primary effusion lymphoma. In contrast to HHV-8, which was positive in all nine cases tested (100%), HIV was found in 75% (9/12) of cases, whereas the three HIV-negative cases were either in elderly patients (one with hepatitis C virus infection and one with asbestoses exposure) or in a heart transplantation recipient. By flow cytometry, the antigens expressed in descending order were CD38, CD71, HLA-DR, CD30, and CD45RO. B-cell markers were largely negative. Cytomorphologically, all cases showed atypical to anaplastic morphology. Notch1, a member of transmembrane signal transduction family, was found in six of seven HHV-8-positive cases (86%). In agreement with in vitro studies using human primary effusion lymphoma cell lines, we have found that Notch1 was expressed in the majority of HHV-8-positive primary effusion lymphoma cases, corroborating the notion that Notch1 may have an important role in HHV-8-mediated lymphomagenesis of primary effusion lymphoma.

    Title Significant Cd5 Expression on Normal Stage 3 Hematogones and Mature B Lymphocytes in Bone Marrow.
    Date November 2009
    Journal American Journal of Clinical Pathology

    B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.

    Title Multiparameter Flow Cytometric Analysis Reveals Low Percentage of Bone Marrow Hematogones in Myelodysplastic Syndromes.
    Date March 2008
    Journal American Journal of Clinical Pathology

    Diagnosis of myelodysplastic syndromes (MDS) could be difficult. We explored the usefulness of the enumeration of maturing B-lineage precursors (hematogones) by multiparameter flow cytometric analysis in the diagnosis of MDS in bone marrow (BM) specimens. We evaluated 111 MDS, 120 non-MDS (most with cytopenias; control group 1), and 41 noncytopenic lymphoma staging BM (control group 2) specimens. The percentage of total hematogones was significantly lower in MDS (median, 0%; mean, 0.10%) compared with non-MDS (control group 1, median, 0.38%, and mean, 0.91%; control group 2, median, 0.38%, and mean, 0.60%; P < .0001), as was the percentage of the most immature (stage I) hematogones. Thus, hematogone enumeration may serve as a biomarker to aid in the diagnosis of MDS. Interestingly, the percentage of hematogones was not significantly different between MDS subgroups or patients with MDS with and without chromosomal abnormalities, implying that a defect in maturing B-cell precursors may be an early event in the pathogenesis of MDS.

    Title Current Methods of Colorectal Cancer Screening.
    Date June 2002
    Journal Mlo: Medical Laboratory Observer

    Similar doctors nearby

    Dr. Sunati Sahoo

    21 years experience
    Dallas, TX

    Dr. Mohammad Ansari

    Anatomic Pathology & Clinical Pathology
    28 years experience
    Dallas, TX

    Dr. Dinesh Rakheja

    Anatomic Pathology
    19 years experience
    Dallas, TX

    Dr. Emily Herndon

    Anatomic Pathology
    13 years experience
    Dallas, TX

    Dr. Kyle Molberg

    Anatomic Pathology
    27 years experience
    Dallas, TX

    Dr. Paul Southern

    Internal Medicine
    Dallas, TX
    Search All Similar Doctors